Stroger Hospital and the CORE Center
Chicago, Illinois, 60612, United States
NCT Number: NCT02371525
To test the effectiveness of Prepmate, a novel multi-modal, technology-based intervention for pre-exposure prophylaxis (PrEP) adherence support among young men who have sex with men (MSM).
Looking for future studies?
Notify Me18 year–29 year
Male
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A novel multi-modal, technology-based intervention for pre-exposure prophylaxis (PrEP) adherence support .
Time frame: DBS measured through week 36
PrEP adherence during follow-up based on dried blood spot (DBS) concentrations.
Time frame: baseline and week 36
Change in PrEP knowledge assessed via computer-assisted self-interview (CASI) at baseline and week 36 (or early termination)
Time frame: baseline through week 36
Change in self-reported sexual risk behavior administered via CASI
Time frame: baseline through week 36
Changes in risk perception during the study administered by CASI
Time frame: Month 9 (or early termination)
Acceptability of Prepmate as measured by an acceptability index collected via CASI at 9 months (or early termination).
Time frame: Month 10
Qualitative feedback provided via individual exit interviews with a subset of participants one month after Prepmate termination. Interviews will be open-ended and will cover topics such as usability, acceptability, user-experience and effectiveness of the Prepmate intervention.
Time frame: through week 36
Use patterns of Prepmate texting service over time as measured by responses to text messages.
Time frame: through week 36
Incidence of a combination endpoint of gonorrhea, chlamydia, and/or syphilis.
Time frame: week 36
The number of HIV infections (2) The drug resistance profiles of breakthrough infections
University of California, San Francisco
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06125509
HIV
Tallahassee, Florida, United States
View Trial DetailsNCT07225894
Behavior, HIV
Kisumu, Kisumu County, Kenya
View Trial DetailsNCT02447159
Behavior, Blood-Borne Infections
Eket, Akwa Ibom State, Nigeria
View Trial DetailsNCT03734393
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Birmingham, Alabama, United States
View Trial Details